| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |